June 7, 2013 | The Leukemia & Lymphoma Society and Dana-Farber Cancer Institute have joined forces to create a network of sites in community oncology settings across the country for clinical trial testing specifically focused in blood cancer therapies. This Blood Cancer Research Partnership (BCRP) will address the major bottleneck: the need for more patients. With eleven potential sites already identified, the BCRP will bring cutting-edge clinical research to a wider spectrum of patients with blood cancers. Dana-Farber Cancer Institute